Detalles de la búsqueda
1.
Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid.
Ann Pharmacother
; 56(4): 401-411, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382435
2.
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study.
J Clin Pharm Ther
; 47(12): 2020-2029, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35929568
3.
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search.
J Med Internet Res
; 24(3): e31016, 2022 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35254286
4.
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey.
J Med Internet Res
; 24(9): e37445, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36099018
5.
Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases.
Oncologist
; 25(5): e861-e869, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32045052
6.
A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis.
Med Mycol
; 58(3): 300-309, 2020 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231772
7.
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients.
Ann Pharmacother
; 54(7): 633-643, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31910643
8.
A Case-Control Study of Real-Life Experience with Ceftolozane-Tazobactam in Patients with Hematologic Malignancy and Pseudomonas aeruginosa Infection.
Antimicrob Agents Chemother
; 63(2)2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30530598
9.
Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.
Ann Pharmacother
; 52(1): 11-18, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836468
10.
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project.
Int J Clin Pract
; 71(8)2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28836363
11.
Switching to a rilpivirine/emtricitabine/tenofovir single-tablet regimen in RNA-suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks.
Int J Clin Pract
; 71(8)2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28722790
12.
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice.
Ann Pharmacother
; 50(11): 901-908, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27422641
13.
Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury.
Am J Ther
; 27(6): e670-e671, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31356341
14.
Effects of a pharmacist designed clinical decision support system on antimicrobial stewardship.
Appl Clin Inform
; 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38857881
15.
Perceived quality of life by patients with immune-mediated inflammatory diseases treated with biological therapies. SACVINFA study.
Farm Hosp
; 2024 May 23.
Artículo
en Inglés, Español
| MEDLINE | ID: mdl-38789316
16.
Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent COVID-19 progression in hematological patients: an observational study.
Pharmacol Rep
; 75(5): 1254-1264, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37656351
17.
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy.
Farm Hosp
; 46(7): 36-46, 2022 10 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36520559
18.
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare.
Front Immunol
; 13: 915578, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35967330
19.
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
Int J Antimicrob Agents
; 57(2): 106249, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259918
20.
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
Expert Rev Clin Pharmacol
; 14(2): 249-260, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33499687